Vivesto AB OASMY Stock
Vivesto AB Price Chart
Vivesto AB OASMY Financial and Trading Overview
| Vivesto AB stock price | 0.02 USD |
| Previous Close | 0.0002 USD |
| Open | 0.0002 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0002 - 0.0002 USD |
| 52 Week Range | 0.0002 - 0.35 USD |
| Volume | 100 USD |
| Avg. Volume | 4 USD |
| Market Cap | 14.85M USD |
| Beta (5Y Monthly) | 0.076628 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.16 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | March 25, 2022 |
| 1y Target Est | N/A |
OASMY Valuation Measures
| Enterprise Value | 35.87K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Vivesto AB Stock Price History
| Beta (5Y Monthly) | 0.076628 |
| 52-Week Change | -99.90% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.35 USD |
| 52 Week Low | 0.0002 USD |
| 50-Day Moving Average | 0.03 USD |
| 200-Day Moving Average | 0.08 USD |
OASMY Share Statistics
| Avg. Volume (3 month) | 4 USD |
| Avg. Daily Volume (10-Days) | 10 USD |
| Shares Outstanding | 179.35M |
| Float | 134.6M |
| Short Ratio | 0.03 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 20.72K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.020% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | -283.55% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.72% |
| Return on Equity (ttm) | -72.83% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -2289000 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.19 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 2.59 USD |
| Current Ratio (mrq) | 6.201 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Vivesto AB
| Country | United States |
| State | N/A |
| City | Solna |
| Address | Gustav III:s Boulevard 46 |
| ZIP | 169 73 |
| Phone | 46 18 50 54 40 |
| Website | https://www.vivesto.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
Q&A For Vivesto AB Stock
What is a current OASMY stock price?
Vivesto AB OASMY stock price today per share is 0.02 USD.
How to purchase Vivesto AB stock?
You can buy OASMY shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vivesto AB?
The stock symbol or ticker of Vivesto AB is OASMY.
Which industry does the Vivesto AB company belong to?
The Vivesto AB industry is Drug Manufacturers-Specialty & Generic.
How many shares does Vivesto AB have in circulation?
The max supply of Vivesto AB shares is 779.74M.
What is Vivesto AB Price to Earnings Ratio (PE Ratio)?
Vivesto AB PE Ratio is now.
What was Vivesto AB earnings per share over the trailing 12 months (TTM)?
Vivesto AB EPS is -0.16 USD over the trailing 12 months.
Which sector does the Vivesto AB company belong to?
The Vivesto AB sector is Healthcare.